Skip to main content

Cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) for remission induction in children with advanced acute lymphatic leukemia (ALL)

Publication ,  Journal Article
Steuber, CP; Fernbach, DJ; Starling, KA; Falletta, JM
Published in: Proceedings of the American Association for Cancer Research
January 1, 1974

Duke Scholars

Published In

Proceedings of the American Association for Cancer Research

Publication Date

January 1, 1974

Volume

Vol. 15
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Steuber, C. P., Fernbach, D. J., Starling, K. A., & Falletta, J. M. (1974). Cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) for remission induction in children with advanced acute lymphatic leukemia (ALL). Proceedings of the American Association for Cancer Research, Vol. 15.
Steuber, C. P., D. J. Fernbach, K. A. Starling, and J. M. Falletta. “Cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) for remission induction in children with advanced acute lymphatic leukemia (ALL).” Proceedings of the American Association for Cancer Research Vol. 15 (January 1, 1974).
Steuber CP, Fernbach DJ, Starling KA, Falletta JM. Cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) for remission induction in children with advanced acute lymphatic leukemia (ALL). Proceedings of the American Association for Cancer Research. 1974 Jan 1;Vol. 15.
Steuber, C. P., et al. “Cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) for remission induction in children with advanced acute lymphatic leukemia (ALL).” Proceedings of the American Association for Cancer Research, vol. Vol. 15, Jan. 1974.
Steuber CP, Fernbach DJ, Starling KA, Falletta JM. Cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) for remission induction in children with advanced acute lymphatic leukemia (ALL). Proceedings of the American Association for Cancer Research. 1974 Jan 1;Vol. 15.

Published In

Proceedings of the American Association for Cancer Research

Publication Date

January 1, 1974

Volume

Vol. 15